封面
市场调查报告书
商品编码
1679362

全球体外诊断市场:市场规模、份额、趋势分析(按产品、测试地点、最终用途、应用、技术和地区)、细分市场预测(2025-2030 年)

In Vitro Diagnostics Market Size, Share & Trends Analysis Report By Product, By Test Location, By End Use, By Application, By Technology, By Region, And Segment Forecasts, 2025 - 2030

出版日期: | 出版商: Grand View Research | 英文 320 Pages | 商品交期: 2-10个工作天内

价格

体外诊断市场的成长与趋势:

预计到 2030 年全球体外诊断市场规模将达到 1,501.3 亿美元,2025 年至 2030 年的复合年增长率为 5.62%。

老年人口的成长、新冠肺炎疫情以及诊断技术的进步推动了它的广泛应用。便携性、准确性和成本效益的技术进步预计将成为渲染影响的最大驱动因素。随着新冠肺炎体外(IVD)诊断技术的推出,技术进步进一步加速,PCR等技术的设备和耗材的使用也得到加强。该市场的竞争对手越来越多地采用合约和伙伴关係策略来确保製造商和用户之间的业务稳定流动。

这些合约也是政府实验室采取严格的价格控制策略的结果,降低了政府环境下的价格。例如,2021 年 4 月,Seegene 公司义大利子公司获得了价值 1.0825 亿美元的公共采购竞标,用于供应萃取试剂以及 715 万个 SARS-CoV-2 诊断测试。 SARS-CoV-2 诊断检测的主要目的是供应 SARS-CoV-2 诊断检测试剂和 SARS-CoV-2 萃取试剂,这增加了供应链的多方贸易和复杂性。全球癌症和心血管疾病(CVD)的高发性预计将推动诊断创新,以促进早期诊断并满足消费者不断变化的需求。预计等离子体 PCR 等新技术将在预测期内商业性进入市场,对现有产品的业务产生不利影响。

体外诊断市场:分析概述

  • 体外诊断(IVD)市场表现出高度的技术创新,这得益于分子诊断、次世代定序(NGS)和PoC测试的进步。
  • 体外诊断(IVD)市场的分销管道在产品如何到达医疗机构、实验室和最终用户方面发挥着至关重要的作用,影响市场覆盖率和业务效率。
  • 体外诊断(IVD)产品的定价根据产品类型、复杂性和应用而有很大差异。
  • 到 2024 年,试剂将占据体外诊断市场的最大份额,达到 65.54%,这主要得益于领先市场参与者开发创新生物标记试剂套件的研发努力。
  • 北美在体外诊断产业占据主导地位,2024 年的份额为 47.43%。

目录

第一章 分析方法及范围

第 2 章执行摘要

第 3 章体外诊断市场:驱动因素、趋势与范围

  • 市场联动展望
    • 母市场展望
    • 相关/附随市场展望
  • 市场动态
    • 市场驱动因素分析
    • 市场限制分析
    • 市场机会分析
    • 供应链分析
    • 分销管道
  • 体外诊断市场:分析工具
    • 产业分析:波特五力分析
    • PESTEL 分析
  • IVD 和 LDT 报销:概述
  • 定价分析

第 4 章体外诊断市场:按产品分類的估计和趋势分析

  • 细分仪表板
  • 体外诊断市场:按产品分類的趋势分析(2024 年和 2030 年)
  • 装置
  • 设备:市场收益估计与预测(金额(十亿美元)、数量(千台),2018 年至 2030 年)
  • 试剂
  • 服务

第 5 章体外诊断市场:按技术分類的估计和趋势分析

  • 细分仪表板
  • 体外诊断市场:依技术分類的趋势分析(2024 年和 2030 年)
  • 免疫检测
    • 装置
    • 试剂
    • 服务
  • 血液学
    • 装置
    • 试剂
    • 服务
  • 临床化学
    • 装置
    • 试剂
    • 服务
  • 分子诊断
    • 装置
    • 试剂
    • 服务
  • 凝血
    • 装置
    • 试剂
    • 服务
  • 微生物
    • 装置
    • 试剂
    • 服务
  • 其他的
    • 装置
    • 试剂
    • 服务

第 6 章体外诊断市场:按应用分類的估计和趋势分析

  • 细分仪表板
  • 体外诊断市场:按应用分類的趋势分析(2024 年和 2030 年)
  • 感染疾病
  • 糖尿病
  • 肿瘤学/癌症
  • 心臟病学
  • 肾臟病学
  • 自体免疫疾病
  • 药物检测
  • 其他的

第 7 章体外诊断市场:按测试地点进行的估计和趋势分析

  • 细分仪表板
  • 体外诊断市场:按测试地点分類的趋势分析(2024 年和 2030 年)
  • 照护现场
  • 居家医疗
  • 其他的

第 8 章体外诊断市场:依最终用途的估计与趋势分析

  • 细分仪表板
  • 体外诊断市场:趋势分析,依最终用途(2024 年和 2030 年)
  • 医院
  • 实验室
  • 居家医疗
  • 其他的

第 9 章体外诊断市场:按地区分類的估计和趋势分析

  • 各地区体外诊断市场占有率(十亿美元,2024 年和 2030 年)
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 瑞典
    • 丹麦
    • 挪威
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 泰国
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 南非
    • 科威特

第十章 竞争格局

  • 主要市场参与企业的近期趋势及影响分析
  • 公司分类
  • 全球公司市场占有率分析(2024 年)
  • 公司热图分析
  • 战略地图
    • 扩张
    • 企业合併与收购 (M&A)
    • 伙伴关係和合作
    • 新产品发布
    • 研究与开发
  • 公司简介
    • Abbott
    • Bio-Rad Laboratories, Inc
    • Siemens Healthineers AG
    • BIOMERIEUX
    • BD
    • QIAGEN
    • Quidel Corporation
    • F. Hoffmann-La Roche Ltd.
    • Danaher
    • Quest Diagnostics Incorporated
    • Agilent Technologies, Inc.
Product Code: 978-1-68038-080-4

In Vitro Diagnostic Market Growth & Trends:

The global in vitro diagnostics market size is expected to reach USD 150.13 billion in 2030 and is projected to grow at a CAGR of 5.62% from 2025 to 2030. driven by the increasing geriatric population, COVID-19 pandemic, and technological advancements in diagnostics that are supporting its adoption. Technological advancements in terms of portability, accuracy, and cost-effectiveness are projected to be one of the high-impact rendering drivers. Technological advancements were further accelerated by the launch of COVID-19 IVD diagnostics and enhanced the adoption of instruments and consumables for technologies, such as PCR. Competitors in the market are increasingly adopting agreement and partnership strategies to maintain a constant flow of business for manufacturers & diagnostics for users.

These agreements are also a result of the harsh price containment strategies for government laboratories, which lowers the price in government settings. For instance, in April 2021, the Italian subsidiary of Seegene, Inc. received a USD 108.25 million tenders for public procurement for the supply of extraction reagents, as well as 7.15 million SARS-CoV-2 diagnostic tests. However, it increases the multiparty nature and complexity of the supply chain. The high prevalence of cancer and Cardiovascular Diseases (CVDs) globally is anticipated to drive diagnostic innovation to facilitate early diagnosis and meet the constantly evolving needs of consumers. Novel technologies, such as plasmonic PCR, are anticipated to commercially enter the market during the forecast period, influencing the business of existing products adversely.

In Vitro Diagnostics Market Report Highlights:

  • The IVD market demonstrates a high degree of innovation, driven by advancements in molecular diagnostics, next-generation sequencing (NGS), and point-of-care testing.
  • The distribution channels for in vitro diagnostics (IVD) market play a critical role in how products reach healthcare facilities, laboratories, and End Users, impacting market reach and operational efficiency
  • The pricing of In vitro diagnostics (IVD) products varies significantly based on product type, complexity, and application.
  • Reagents held the largest share of 65.54% of the in vitro diagnostics market in 2024, driven by significant R&D efforts from leading market players aiming to develop innovative biomarker kits
  • North America dominated the in vitro diagnostics industry and accounted for a 47.43% share in 2024

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
    • 1.2.1. Product
    • 1.2.2. Technology
    • 1.2.3. Application
    • 1.2.4. Test Location
    • 1.2.5. End Use
  • 1.3. Regional Scope
  • 1.4. Estimates and Forecast Timeline
  • 1.5. Research Methodology
  • 1.6. Information Procurement
    • 1.6.1. Purchased Database
    • 1.6.2. GVR's Internal Database
  • 1.7. Details of primary research
  • 1.8. Market Formulation & Validation
  • 1.9. Model Details
    • 1.9.1. Commodity flow analysis (Model 1)
      • 1.9.1.1. Approach 1: Commodity flow approach
    • 1.9.2. Volume price analysis (Model 2)
      • 1.9.2.1. Approach 2: Volume price analysis
  • 1.10. Research Scope and Assumptions
    • 1.10.1. List of Secondary Sources
    • 1.10.2. List of Primary Sources
    • 1.10.3. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. In Vitro Diagnostics Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Drivers Analysis
      • 3.2.1.1. Introduction of Technologically Advanced Products
      • 3.2.1.2. Increasing Demand for PoC Testing
      • 3.2.1.3. Growing Prevalence of Target Diseases
      • 3.2.1.4. Increasing External Funding for R&D
    • 3.2.2. Market Restraints Analysis
      • 3.2.2.1. Presence of Ambiguous Regulatory Framework
      • 3.2.2.2. High Capital Investment
      • 3.2.2.3. High Prices of Molecular Diagnostic Tests
    • 3.2.3. Market Opportunity Analysis
    • 3.2.4. Supply Chain Analysis
    • 3.2.5. Distribution Channel
      • 3.2.5.1. Direct Sales
      • 3.2.5.2. Distributors Network
      • 3.2.5.3. E-commerce and Online Platforms
      • 3.2.5.4. Major Distributors
  • 3.3. In Vitro Diagnostics Market Analysis Tools
    • 3.3.1. Porter's Analysis
      • 3.3.1.1. Bargaining power of the suppliers
      • 3.3.1.2. Bargaining power of the buyers
      • 3.3.1.3. Threats of substitution
      • 3.3.1.4. Threats from new entrants
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Economic and Social landscape
      • 3.3.2.3. Technological landscape
      • 3.3.2.4. Legal landscape
  • 3.4. Reimbursement Overview of IVDs and LDTs
  • 3.5. Pricing Analysis

Chapter 4. In Vitro Diagnostics Market: Product Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. In Vitro Diagnostics Market: Product Movement Analysis, 2024 & 2030 (USD Billion)
  • 4.3. Instruments
  • 4.4. Instruments Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion) (Volume, Number of Instruments, in Thousands)Reagents
    • 4.4.1. Reagents Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion) (Volume, Reagents, Number of Tests in Million)
  • 4.5. Services
    • 4.5.1. Services Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)

Chapter 5. In Vitro Diagnostics Market: Technology Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. In Vitro Diagnostics Market: Technology Movement Analysis, 2024 & 2030 (USD Billion)
  • 5.3. Immunoassay
    • 5.3.1. Immunoassay Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
    • 5.3.2. Instruments
      • 5.3.2.1. Instruments Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion) (Volume, Number of Units)
    • 5.3.3. Reagents
      • 5.3.3.1. Reagents Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion) (Volume, Reagents, Number of Tests in Million)
    • 5.3.4. Services
      • 5.3.4.1. Services Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 5.4. Hematology
    • 5.4.1. Hematology Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
    • 5.4.2. Instruments
      • 5.4.2.1. Instruments Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion) (Volume, Number of Instruments, in Thousands)
    • 5.4.3. Reagents
      • 5.4.3.1. Reagents Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion) (Volume, Reagents, Number of Tests in Million)
    • 5.4.4. Services
      • 5.4.4.1. Services Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 5.5. Clinical Chemistry
    • 5.5.1. Clinical Chemistry Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
    • 5.5.2. Instruments
      • 5.5.2.1. Instruments Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion) (Volume, Number of Instruments, in Thousands)
    • 5.5.3. Reagents
      • 5.5.3.1. Reagents Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion) (Volume, Reagents, Number of Tests in Million)
    • 5.5.4. Services
      • 5.5.4.1. Services Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 5.6. Molecular Diagnostics
    • 5.6.1. Molecular Diagnostics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
    • 5.6.2. Instruments
      • 5.6.2.1. Instruments Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion) (Volume, Number of Instruments, in Thousands)
    • 5.6.3. Reagents
      • 5.6.3.1. Reagents Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion) (Volume, Reagents, Number of Tests in Million)
    • 5.6.4. Services
      • 5.6.4.1. Services Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 5.7. Coagulation
    • 5.7.1. Coagulation Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
    • 5.7.2. Instruments
      • 5.7.2.1. Instruments Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion) (Volume, Number of Instruments, in Thousands)
    • 5.7.3. Reagents
      • 5.7.3.1. Reagents Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion) (Volume, Reagents, Number of Tests in Million)
    • 5.7.4. Services
      • 5.7.4.1. Services Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 5.8. Microbiology
    • 5.8.1. Microbiology Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
    • 5.8.2. Instruments
      • 5.8.2.1. Instruments Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion) (Volume, Number of Instruments, in Thousands)
    • 5.8.3. Reagents
      • 5.8.3.1. Reagents Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion) (Volume, Reagents, Number of Tests in Million)
    • 5.8.4. Services
      • 5.8.4.1. Services Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 5.9. Others
    • 5.9.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
    • 5.9.2. Instruments
      • 5.9.2.1. Instruments Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion) (Volume, Number of Instruments, in Thousands)
    • 5.9.3. Reagents
      • 5.9.3.1. Reagents Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion) (Volume, Reagents, Number of Tests in Million)
    • 5.9.4. Services
      • 5.9.4.1. Services Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)

Chapter 6. In Vitro Diagnostics Market: Application Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. In Vitro Diagnostics Market: Application Movement Analysis, 2024 & 2030 (USD Billion)
  • 6.3. Infectious Disease
    • 6.3.1. Infectious Disease Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 6.4. Diabetes
    • 6.4.1. Diabetes Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 6.5. Oncology/Cancer
    • 6.5.1. Oncology/Cancer Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 6.6. Cardiology
    • 6.6.1. Cardiology Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 6.7. Nephrology
    • 6.7.1. Nephrology Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 6.8. Autoimmune Diseases
    • 6.8.1. Autoimmune Diseases Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 6.9. Drug Testing
    • 6.9.1. Drug Testing Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 6.10. Others
    • 6.10.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)

Chapter 7. In Vitro Diagnostics Market: Test Location Estimates & Trend Analysis

  • 7.1. Segment Dashboard
  • 7.2. In Vitro Diagnostics Market: Test Location Movement Analysis, 2024 & 2030 (USD Billion)
  • 7.3. Point of Care
    • 7.3.1. Point of Care Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 7.4. Home-care
    • 7.4.1. Home-care Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 7.5. Others
    • 7.5.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)

Chapter 8. In Vitro Diagnostics Market: End Use Estimates & Trend Analysis

  • 8.1. Segment Dashboard
  • 8.2. In Vitro Diagnostics Market: End Use Movement Analysis, 2024 & 2030 (USD Billion)
  • 8.3. Hospitals
    • 8.3.1. Hospitals Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
  • 8.4. Laboratory
    • 8.4.1. Laboratory Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
  • 8.5. Home Care
    • 8.5.1. Home Care Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
  • 8.6. Others
    • 8.6.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)

Chapter 9. In Vitro Diagnostics Market: Regional Estimates & Trend Analysis

  • 9.1. In Vitro Diagnostics Market Share, By Region, 2024 & 2030, USD Billion
  • 9.2. North America
    • 9.2.1. North America In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
    • 9.2.2. U.S.
      • 9.2.2.1. Key Country Dynamics
      • 9.2.2.2. Regulatory Landscape/Reimbursement Scenario
      • 9.2.2.3. Competitive Insights
      • 9.2.2.4. U.S. In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
    • 9.2.3. Canada
      • 9.2.3.1. Key Country Dynamics
      • 9.2.3.2. Regulatory Landscape/Reimbursement Scenario
      • 9.2.3.3. Competitive Insights
      • 9.2.3.4. Canada In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
    • 9.2.4. Mexico
      • 9.2.4.1. Key Country Dynamics
      • 9.2.4.2. Regulatory Landscape/Reimbursement Scenario
      • 9.2.4.3. Competitive Insights
      • 9.2.4.4. Mexico In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
  • 9.3. Europe
    • 9.3.1. Europe In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
    • 9.3.2. U.K.
      • 9.3.2.1. Key Country Dynamics
      • 9.3.2.2. Regulatory Landscape/Reimbursement Scenario
      • 9.3.2.3. Competitive Insights
      • 9.3.2.4. U.K. In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
    • 9.3.3. Germany
      • 9.3.3.1. Key Country Dynamics
      • 9.3.3.2. Regulatory Landscape/Reimbursement Scenario
      • 9.3.3.3. Competitive Insights
      • 9.3.3.4. Germany In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
    • 9.3.4. France
      • 9.3.4.1. Key Country Dynamics
      • 9.3.4.2. Regulatory Landscape/Reimbursement Scenario
      • 9.3.4.3. Competitive Insights
      • 9.3.4.4. France In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
    • 9.3.5. Italy
      • 9.3.5.1. Key Country Dynamics
      • 9.3.5.2. Regulatory Landscape/Reimbursement Scenario
      • 9.3.5.3. Competitive Insights
      • 9.3.5.4. Italy In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
    • 9.3.6. Spain
      • 9.3.6.1. Key Country Dynamics
      • 9.3.6.2. Regulatory Landscape/Reimbursement Scenario
      • 9.3.6.3. Competitive Insights
      • 9.3.6.4. Spain In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
    • 9.3.7. Sweden
      • 9.3.7.1. Key Country Dynamics
      • 9.3.7.2. Regulatory Landscape/Reimbursement Scenario
      • 9.3.7.3. Competitive Insights
      • 9.3.7.4. Sweden In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
    • 9.3.8. Denmark
      • 9.3.8.1. Key Country Dynamics
      • 9.3.8.2. Regulatory Landscape/Reimbursement Scenario
      • 9.3.8.3. Competitive Insights
      • 9.3.8.4. Denmark In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
    • 9.3.9. Norway
      • 9.3.9.1. Key Country Dynamics
      • 9.3.9.2. Regulatory Landscape/Reimbursement Scenario
      • 9.3.9.3. Competitive Insights
      • 9.3.9.4. Norway In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
  • 9.4. Asia Pacific
    • 9.4.1. Asia Pacific In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 9.4.2. China
      • 9.4.2.1. Key Country Dynamics
      • 9.4.2.2. Regulatory Landscape/Reimbursement Scenario
      • 9.4.2.3. Competitive Insights
      • 9.4.2.4. China In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
    • 9.4.3. Japan
      • 9.4.3.1. Key Country Dynamics
      • 9.4.3.2. Regulatory Landscape/Reimbursement Scenario
      • 9.4.3.3. Competitive Insights
      • 9.4.3.4. Japan In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
    • 9.4.4. India
      • 9.4.4.1. Key Country Dynamics
      • 9.4.4.2. Regulatory Landscape/Reimbursement Scenario
      • 9.4.4.3. Competitive Insights
      • 9.4.4.4. India In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
    • 9.4.5. South Korea
      • 9.4.5.1. Key Country Dynamics
      • 9.4.5.2. Regulatory Landscape/Reimbursement Scenario
      • 9.4.5.3. Competitive Insights
      • 9.4.5.4. South Korea In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
    • 9.4.6. Australia
      • 9.4.6.1. Key Country Dynamics
      • 9.4.6.2. Regulatory Landscape/Reimbursement Scenario
      • 9.4.6.3. Competitive Insights
      • 9.4.6.4. Australia In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
    • 9.4.7. Thailand
      • 9.4.7.1. Key Country Dynamics
      • 9.4.7.2. Regulatory Landscape/Reimbursement Scenario
      • 9.4.7.3. Competitive Insights
      • 9.4.7.4. Thailand In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
  • 9.5. Latin America
    • 9.5.1. Latin America In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
    • 9.5.2. Brazil
      • 9.5.2.1. Key Country Dynamics
      • 9.5.2.2. Regulatory Landscape/Reimbursement Scenario
      • 9.5.2.3. Competitive Insights
      • 9.5.2.4. Brazil In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
    • 9.5.3. Argentina
      • 9.5.3.1. Key Country Dynamics
      • 9.5.3.2. Regulatory Landscape/Reimbursement Scenario
      • 9.5.3.3. Competitive Insights
      • 9.5.3.4. Argentina In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
  • 9.6. Middle East and Africa
    • 9.6.1. Middle East and Africa In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
    • 9.6.2. Saudi Arabia
      • 9.6.2.1. Key Country Dynamics
      • 9.6.2.2. Regulatory Landscape/Reimbursement Scenario
      • 9.6.2.3. Competitive Insights
      • 9.6.2.4. Saudi Arabia In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
    • 9.6.3. UAE
      • 9.6.3.1. Key Country Dynamics
      • 9.6.3.2. Regulatory Landscape/Reimbursement Scenario
      • 9.6.3.3. Competitive Insights
      • 9.6.3.4. UAE In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
    • 9.6.4. South Africa
      • 9.6.4.1. Key Country Dynamics
      • 9.6.4.2. Regulatory Landscape/Reimbursement Scenario
      • 9.6.4.3. Competitive Insights
      • 9.6.4.4. South Africa In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
    • 9.6.5. Kuwait
      • 9.6.5.1. Key Country Dynamics
      • 9.6.5.2. Regulatory Landscape/Reimbursement Scenario
      • 9.6.5.3. Competitive Insights
      • 9.6.5.4. Kuwait In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)

Chapter 10. Competitive Landscape

  • 10.1. Recent Developments & Impact Analysis by Key Market Participants
  • 10.2. Company Categorization
  • 10.3. Global Company Market Share Analysis, 2024
  • 10.4. Company Heat Map Analysis
  • 10.5. Strategy Mapping
    • 10.5.1. Expansion
    • 10.5.2. Mergers & Acquisition
    • 10.5.3. Partnerships & Collaborations
    • 10.5.4. New Product Launches
    • 10.5.5. Research And Development
  • 10.6. Company Profiles
    • 10.6.1. Abbott
      • 10.6.1.1. Participant's Overview
      • 10.6.1.2. Financial Performance
      • 10.6.1.3. Product Benchmarking
      • 10.6.1.4. Recent Developments
    • 10.6.2. Bio-Rad Laboratories, Inc
      • 10.6.2.1. Participant's Overview
      • 10.6.2.2. Financial Performance
      • 10.6.2.3. Product Benchmarking
      • 10.6.2.4. Recent Developments
    • 10.6.3. Siemens Healthineers AG
      • 10.6.3.1. Participant's Overview
      • 10.6.3.2. Financial Performance
      • 10.6.3.3. Product Benchmarking
      • 10.6.3.4. Recent Developments
    • 10.6.4. BIOMERIEUX
      • 10.6.4.1. Participant's Overview
      • 10.6.4.2. Financial Performance
      • 10.6.4.3. Product Benchmarking
      • 10.6.4.4. Recent Developments
    • 10.6.5. BD
      • 10.6.5.1. Participant's Overview
      • 10.6.5.2. Financial Performance
      • 10.6.5.3. Product Benchmarking
      • 10.6.5.4. Recent Developments
    • 10.6.6. QIAGEN
      • 10.6.6.1. Participant's Overview
      • 10.6.6.2. Financial Performance
      • 10.6.6.3. Product Benchmarking
      • 10.6.6.4. Recent Developments
    • 10.6.7. Quidel Corporation
      • 10.6.7.1. Participant's Overview
      • 10.6.7.2. Financial Performance
      • 10.6.7.3. Product Benchmarking
      • 10.6.7.4. Recent Developments
    • 10.6.8. F. Hoffmann-La Roche Ltd.
      • 10.6.8.1. Participant's Overview
      • 10.6.8.2. Financial Performance
      • 10.6.8.3. Product Benchmarking
      • 10.6.8.4. Recent Developments
    • 10.6.9. Danaher
      • 10.6.9.1. Participant's Overview
      • 10.6.9.2. Financial Performance
      • 10.6.9.3. Product Benchmarking
      • 10.6.9.4. Recent Developments
    • 10.6.10. Quest Diagnostics Incorporated
      • 10.6.10.1. Participant's Overview
      • 10.6.10.2. Financial Performance
      • 10.6.10.3. Product Benchmarking
      • 10.6.10.4. Recent Developments
    • 10.6.11. Agilent Technologies, Inc.
      • 10.6.11.1. Participant's Overview
      • 10.6.11.2. Financial Performance
      • 10.6.11.3. Product Benchmarking
      • 10.6.11.4. Recent Developments

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 Regulatory Framework
  • Table 4 Global In Vitro Diagnostics Market, By Region, 2018 - 2030 (USD Billion), Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million
  • Table 5 Global In Vitro Diagnostics Market, By Product, 2018 - 2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
  • Table 6 Global In Vitro Diagnostics Market, By Technology, 2018 - 2030 (USD Billion), Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million
  • Table 7 Global In Vitro Diagnostics Market, By Application, 2018 - 2030 USD Billion
  • Table 8 Global In Vitro Diagnostics Market, By End Use, 2018 - 2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
  • Table 9 Global In Vitro Diagnostics Market, By Test Location, 2018 - 2030 (USD Billion)
  • Table 10 North America In Vitro Diagnostics Market, By Country, 2018 - 2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
  • Table 11 North America In Vitro Diagnostics Market, By Product, 2018 - 2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
  • Table 12 North America In Vitro Diagnostics Market, By Technology, 2018 - 2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
  • Table 13 North America In Vitro Diagnostics Market, By Application, 2018 - 2030 (USD Billion)
  • Table 14 North America In Vitro Diagnostics Market, By End Use, 2018 - 2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
  • Table 15 North America In Vitro Diagnostics Market, By Test Location, 2018 - 2030 (USD Billion)
  • Table 16 U.S. In Vitro Diagnostics Market, By Product, 2018 - 2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
  • Table 17 U.S. In Vitro Diagnostics Market, By Technology, 2018 - 2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
  • Table 18 U.S. In Vitro Diagnostics Market, By Application, 2018 - 2030 (USD Billion)
  • Table 19 U.S. In Vitro Diagnostics Market, By End Use, 2018 - 2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
  • Table 20 U.S. In Vitro Diagnostics Market, By Test Location, 2018 - 2030 (USD Billion)
  • Table 21 Canada In Vitro Diagnostics Market, By Product, 2018 - 2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
  • Table 22 Canada In Vitro Diagnostics Market, By Technology, 2018 - 2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
  • Table 23 Canada In Vitro Diagnostics Market, By Application, 2018 - 2030 (USD Billion)
  • Table 24 Canada In Vitro Diagnostics Market, By End Use, 2018 - 2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
  • Table 25 Canada In Vitro Diagnostics Market, By Test Location, 2018 - 2030 (USD Billion)
  • Table 26 Mexico In Vitro Diagnostics Market, By Product, 2018 - 2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
  • Table 27 Mexico In Vitro Diagnostics Market, By Technology, 2018 - 2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
  • Table 28 Mexico In Vitro Diagnostics Market, By Application, 2018 - 2030 (USD Billion)
  • Table 29 Mexico In Vitro Diagnostics Market, By End Use, 2018 - 2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
  • Table 30 Mexico In Vitro Diagnostics Market, By Test Location, 2018 - 2030 (USD Billion)
  • Table 31 Europe In Vitro Diagnostics Market, By Country, 2018 - 2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
  • Table 32 Europe In Vitro Diagnostics Market, By Product, 2018 - 2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
  • Table 33 Europe In Vitro Diagnostics Market, By Technology, 2018 - 2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
  • Table 34 Europe In Vitro Diagnostics Market, By Application, 2018 - 2030 (USD Billion)
  • Table 35 Europe In Vitro Diagnostics Market, By End Use, 2018 - 2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
  • Table 36 Europe In Vitro Diagnostics Market, By Test Location, 2018 - 2030 (USD Billion)
  • Table 37 U.K. In Vitro Diagnostics Market, By Product, 2018 - 2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
  • Table 38 U.K. In Vitro Diagnostics Market, By Technology, 2018 - 2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
  • Table 39 U.K. In Vitro Diagnostics Market, By Application, 2018 - 2030 (USD Billion)
  • Table 40 U.K. In Vitro Diagnostics Market, By End Use, 2018 - 2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
  • Table 41 U.K. In Vitro Diagnostics Market, By Test Location, 2018 - 2030 (USD Billion)
  • Table 42 Germany In Vitro Diagnostics Market, By Product, 2018 - 2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
  • Table 43 Germany In Vitro Diagnostics Market, By Technology, 2018 - 2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
  • Table 44 Germany In Vitro Diagnostics Market, By Application, 2018 - 2030 (USD Billion)
  • Table 45 Germany America In Vitro Diagnostics Market, By End Use, 2018 - 2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
  • Table 46 Germany In Vitro Diagnostics Market, By Test Location, 2018 - 2030 (USD Billion)
  • Table 47 France In Vitro Diagnostics Market, By Product, 2018 - 2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
  • Table 48 France In Vitro Diagnostics Market, By Technology, 2018 - 2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
  • Table 49 France In Vitro Diagnostics Market, By Application, 2018 - 2030 (USD Billion)
  • Table 50 France In Vitro Diagnostics Market, By End Use, 2018 - 2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
  • Table 51 France In Vitro Diagnostics Market, By Test Location, 2018 - 2030 (USD Billion)
  • Table 52 Spain In Vitro Diagnostics Market, By Product, 2018 - 2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
  • Table 53 Spain In Vitro Diagnostics Market, By Technology, 2018 - 2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
  • Table 54 Spain In Vitro Diagnostics Market, By Application, 2018 - 2030 (USD Billion)
  • Table 55 Spain In Vitro Diagnostics Market, By End Use, 2018 - 2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
  • Table 56 Spain In Vitro Diagnostics Market, By Test Location, 2018 - 2030 (USD Billion)
  • Table 57 Italy In Vitro Diagnostics Market, By Product, 2018 - 2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
  • Table 58 Italy In Vitro Diagnostics Market, By Technology, 2018 - 2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
  • Table 59 Italy In Vitro Diagnostics Market, By Application, 2018 - 2030 (USD Billion)
  • Table 60 Italy In Vitro Diagnostics Market, By End Use, 2018 - 2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
  • Table 61 Italy In Vitro Diagnostics Market, By Test Location, 2018 - 2030 (USD Billion)
  • Table 62 Asia Pacific In Vitro Diagnostics Market, By Country, 2018 - 2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
  • Table 63 Asia Pacific In Vitro Diagnostics Market, By Product, 2018 - 2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
  • Table 64 Asia Pacific In Vitro Diagnostics Market, By Technology, 2018 - 2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
  • Table 65 Asia Pacific In Vitro Diagnostics Market, By Application, 2018 - 2030 (USD Billion)
  • Table 66 Asia-Pacific In Vitro Diagnostics Market, By End Use, 2018 - 2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
  • Table 67 Asia-Pacific In Vitro Diagnostics Market, By Test Location, 2018 - 2030 (USD Billion)
  • Table 68 China In Vitro Diagnostics Market, By Product, 2018 - 2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
  • Table 69 China In Vitro Diagnostics Market, By Technology, 2018 - 2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
  • Table 70 China In Vitro Diagnostics Market, By Application, 2018 - 2030 (USD Billion)
  • Table 71 China In Vitro Diagnostics Market, By End Use, 2018 - 2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
  • Table 72 China In Vitro Diagnostics Market, By Test Location, 2018 - 2030 (USD Billion)
  • Table 73 Japan In Vitro Diagnostics Market, By Product, 2018 - 2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
  • Table 74 Japan In Vitro Diagnostics Market, By Technology, 2018 - 2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
  • Table 75 Japan In Vitro Diagnostics Market, By Application, 2018 - 2030 (USD Billion)
  • Table 76 Japan In Vitro Diagnostics Market, By End Use, 2018 - 2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
  • Table 77 Japan In Vitro Diagnostics Market, By Test Location, 2018 - 2030 (USD Billion)
  • Table 78 India In Vitro Diagnostics Market, By Product, 2018 - 2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
  • Table 79 India In Vitro Diagnostics Market, By Technology, 2018 - 2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
  • Table 80 India In Vitro Diagnostics Market, By Application, 2018 - 2030 (USD Billion)
  • Table 81 India In Vitro Diagnostics Market, By End Use, 2018 - 2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
  • Table 82 India In Vitro Diagnostics Market, By Test Location, 2018 - 2030 (USD Billion)
  • Table 83 South Korea In Vitro Diagnostics Market, By Product, 2018 - 2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
  • Table 84 South Korea In Vitro Diagnostics Market, By Technology, 2018 - 2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
  • Table 85 South Korea In Vitro Diagnostics Market, By Application, 2018 - 2030 (USD Billion)
  • Table 86 South Korea In Vitro Diagnostics Market, By End Use, 2018 - 2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
  • Table 87 South Korea In Vitro Diagnostics Market, By Test Location, 2018 - 2030 (USD Billion)
  • Table 88 Australia In Vitro Diagnostics Market, By Product, 2018 - 2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
  • Table 89 Australia In Vitro Diagnostics Market, By Technology, 2018 - 2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
  • Table 90 Australia In Vitro Diagnostics Market, By Application, 2018 - 2030 (USD Billion)
  • Table 91 Australia In Vitro Diagnostics Market, By End Use, 2018 - 2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
  • Table 92 Australia In Vitro Diagnostics Market, By Test Location, 2018 - 2030 (USD Billion)
  • Table 93 Latin America In Vitro Diagnostics Market, By Country, 2018 - 2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
  • Table 94 Latin America In Vitro Diagnostics Market, By Product, 2018 - 2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
  • Table 95 Latin America In Vitro Diagnostics Market, By Technology, 2018 - 2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
  • Table 96 Latin America In Vitro Diagnostics Market, By Application, 2018 - 2030 (USD Billion)
  • Table 97 Latin America In Vitro Diagnostics Market, By End Use, 2018 - 2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
  • Table 98 Latin America In Vitro Diagnostics Market, By Test Location, 2018 - 2030 (USD Billion)
  • Table 99 Brazil In Vitro Diagnostics Market, By Product, 2018 - 2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
  • Table 100 Brazil In Vitro Diagnostics Market, By Technology, 2018 - 2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
  • Table 101 Brazil In Vitro Diagnostics Market, By Application, 2018 - 2030 (USD Billion)
  • Table 102 Brazil In Vitro Diagnostics Market, By End Use, 2018 - 2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
  • Table 103 Brazil In Vitro Diagnostics Market, By Test Location, 2018 - 2030 (USD Billion)
  • Table 104 Argentina In Vitro Diagnostics Market, By Product, 2018 - 2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
  • Table 105 Argentina In Vitro Diagnostics Market, By Technology, 2018 - 2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
  • Table 106 Argentina In Vitro Diagnostics Market, By Application, 2018 - 2030 (USD Billion)
  • Table 107 Argentina In Vitro Diagnostics Market, By End Use, 2018 - 2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
  • Table 108 Argentina In Vitro Diagnostics Market, By Test Location, 2018 - 2030 (USD Billion)
  • Table 109 MEA In Vitro Diagnostics Market, By Country, 2018 - 2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
  • Table 110 MEA In Vitro Diagnostics Market, By Product, 2018 - 2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
  • Table 111 MEA In Vitro Diagnostics Market, By Technology, 2018 - 2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
  • Table 112 MEA In Vitro Diagnostics Market, By Application, 2018 - 2030 (USD Billion)
  • Table 113 MEA In Vitro Diagnostics Market, By End Use, 2018 - 2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
  • Table 114 MEA In Vitro Diagnostics Market, By Test Location, 2018 - 2030 (USD Billion)
  • Table 115 South Africa In Vitro Diagnostics Market, By Product, 2018 - 2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
  • Table 116 South Africa In Vitro Diagnostics Market, By Technology, 2018 - 2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
  • Table 117 South Africa In Vitro Diagnostics Market, By Application, 2018 - 2030 (USD Billion)
  • Table 118 South Africa In Vitro Diagnostics Market, By End Use, 2018 - 2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
  • Table 119 UAE In Vitro Diagnostics Market, By Test Location, 2018 - 2030 (USD Billion)
  • Table 120 UAE In Vitro Diagnostics Market, By Product, 2018 - 2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
  • Table 121 UAE In Vitro Diagnostics Market, By Technology, 2018 - 2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
  • Table 122 UAE In Vitro Diagnostics Market, By Application, 2018 - 2030 (USD Billion)
  • Table 123 UAE In Vitro Diagnostics Market, By End Use, 2018 - 2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
  • Table 124 UAE In Vitro Diagnostics Market, By Test Location, 2018 - 2030 (USD Billion) million
  • Table 125 Saudi Arabia In Vitro Diagnostics Market, By Product, 2018 - 2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
  • Table 126 Saudi Arabia In Vitro Diagnostics Market, By Technology, 2018 - 2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
  • Table 127 Saudi Arabia In Vitro Diagnostics Market, By Application, 2018 - 2030 (USD Billion)
  • Table 128 Saudi Arabia In Vitro Diagnostics Market, By End Use, 2018 - 2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
  • Table 129 Saudi Arabia In Vitro Diagnostics Market, By Test Location, 2018 - 2030 (USD Billion)

List of Figures

  • Fig. 1 In Vitro Diagnostics market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Data triangulation techniques
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 QFD modeling for market share assessment
  • Fig. 8 Market formulation & validation
  • Fig. 9 In vitro diagnostic market snapshot
  • Fig. 10 Parent market outlook, 2024
  • Fig. 11 In vitro diagnostic market driver impact
  • Fig. 12 Global elderly population
  • Fig. 13 New cancer cases by year
  • Fig. 14 In vitro diagnostic market restraint impact
  • Fig. 15 Market entry strategy
  • Fig. 16 SWOT analysis, by factor (political & legal, economic, and technological)
  • Fig. 17 Porter's five forces analysis
  • Fig. 18 IVD market: Product outlook and key takeaways
  • Fig. 19 IVD market: Products movement analysis
  • Fig. 20 Instruments market estimates and forecast, 2018 - 2030 (USD Billion, volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Fig. 21 Reagents market estimates and forecast, 2018 - 2030 (USD Billion, volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Fig. 22 Services market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 23 IVD market: Technology outlook and key takeaways
  • Fig. 24 IVD Market: Technology movement analysis
  • Fig. 25 Immunoassay market estimates and forecast, 2018 - 2030 (USD Billion, volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Fig. 26 Instruments market for immunoassay estimates and forecast, 2018 - 2030 (USD Billion), volume, number of instruments, in thousands
  • Fig. 27 Reagents market for immunoassay estimates and forecast, 2018 - 2030 (USD Billion), volume, reagents, number of tests in million
  • Fig. 28 Services market for immunoassay estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 29 Hematology market estimates and forecast, 2018 - 2030 (USD Billion, volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Fig. 30 Instruments market for hematology estimates and forecast, 2018 - 2030 (USD Billion), volume, number of instruments, in thousands
  • Fig. 31 Reagents market for hematology estimates and forecast, 2018 - 2030 (USD Billion), volume, reagents, number of tests in million
  • Fig. 32 Services market for hematology estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 33 Clinical chemistry market estimates and forecast, 2018 - 2030 (USD Billion, volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Fig. 34 Instruments market for clinical chemistry estimates and forecast, 2018 - 2030 (USD Billion), volume, number of instruments, in thousands
  • Fig. 35 Reagents market for clinical chemistry estimates and forecast, 2018 - 2030 (USD Billion), volume, reagents, number of tests in million
  • Fig. 36 Services market for clinical chemistry estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 37 Molecular diagnostics market estimates and forecast, 2018 - 2030 (USD Billion, volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Fig. 38 Instruments market for molecular diagnostics estimates and forecast, 2018 - 2030 (USD Billion), volume, number of instruments, in thousands
  • Fig. 39 Reagents market for molecular diagnostics estimates and forecast, 2018 - 2030 (USD Billion), volume, reagents, number of tests in million
  • Fig. 40 Services market for molecular diagnostics estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 41 Coagulation market estimates and forecast, 2018 - 2030 (USD Billion, volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Fig. 42 Instruments market for coagulation estimates and forecast, 2018 - 2030 (USD Billion), volume, number of instruments, in thousands
  • Fig. 43 Reagents market for coagulation estimates and forecast, 2018 - 2030 (USD Billion), volume, reagents, number of tests in million
  • Fig. 44 Services market for coagulation estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 45 Microbiology market estimates and forecast, 2018 - 2030 (USD Billion, volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Fig. 46 Instruments market for microbiology estimates and forecast, 2018 - 2030 (USD Billion), volume, number of instruments, in thousands
  • Fig. 47 Reagents market for microbiology estimates and forecast, 2018 - 2030 (USD Billion), volume, reagents, number of tests in million
  • Fig. 48 Services market for microbiology estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 49 Others market estimates and forecast, 2018 - 2030 (USD Billion)billion, volume, number of instruments, in thousands, volume, reagents, number of tests in million
  • Fig. 50 Instruments others market estimates and forecast, 2018 - 2030 (USD Billion), volume, number of instruments, in thousands
  • Fig. 51 Reagents others market estimates and forecast, 2018 - 2030 (USD Billion), volume, reagents, number of tests in million
  • Fig. 52 Services market for other technology estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 53 IVD market: Application outlook and key takeaways
  • Fig. 54 IVD market: Application movement analysis
  • Fig. 55 Infectious diseases market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 56 Diabetes market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 57 Oncology market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 58 Cardiology market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 59 Nephrology market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 60 Autoimmune diseases market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 61 Drug testing market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 62 Others market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 63 IVD market: End Use outlook and key takeaways
  • Fig. 64 IVD treatment market: End Use movement analysis
  • Fig. 65 Hospitals market estimates and forecast, 2018 - 2030 (USD Billion, volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Fig. 66 Laboratory market estimates and forecast, 2018 - 2030 (USD Billion, volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Fig. 67 Home care market estimates and forecast, 2018 - 2030 (USD Billion, volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Fig. 68 Other market estimates and forecast, 2018 - 2030 (USD Billion, volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Fig. 69 IVD market: test location outlook and key takeaways
  • Fig. 70 IVD treatment market: Test location movement analysis
  • Fig. 71 Point-of-care market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 72 Homecare market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 73 Others market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 74 IVD Market: Regional outlook and key takeaways
  • Fig. 75 IVD market: Regional movement analysis
  • Fig. 76 North America
  • Fig. 77 North America. market estimates and forecast, 2018 - 2030 (USD Billion, volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Fig. 78 U.S. key country dynamics
  • Fig. 79 U.S. market estimates and forecast, 2018 - 2030 (USD Billion, volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Fig. 80 Canada key country dynamics
  • Fig. 81 Canada market estimates and forecast, 2018 - 2030 (USD Billion, volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Fig. 82 Mexico key country dynamics
  • Fig. 83 Mexico market estimates and forecast, 2018 - 2030 (USD Billion, volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Fig. 84 Europe
  • Fig. 85 Europe market estimates and forecast, 2018 - 2030 (USD Billion, volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Fig. 86 U.K. key country dynamics
  • Fig. 87 U.K. market estimates and forecast, 2018 - 2030 (USD Billion, volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Fig. 88 Germany key country dynamics
  • Fig. 89 Germany market estimates and forecast, 2018 - 2030 (USD Billion, volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Fig. 90 Spain key country dynamics
  • Fig. 91 Spain market estimates and forecast, 2018 - 2030 (USD Billion, volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Fig. 92 France key country dynamics
  • Fig. 93 France market estimates and forecast, 2018 - 2030 (USD Billion, volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Fig. 94 Italy key country dynamics
  • Fig. 95 Italy market estimates and forecast, 2018 - 2030 (USD Billion, volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Fig. 96 Denmark key country dynamics
  • Fig. 97 Denmark market estimates and forecast, 2018 - 2030 (USD Billion, volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Fig. 98 Sweden key country dynamics
  • Fig. 99 Sweden market estimates and forecast, 2018 - 2030 (USD Billion, volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Fig. 100 Norway key country dynamics
  • Fig. 101 Norway market estimates and forecast, 2018 - 2030 (USD Billion, volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Fig. 102 Asia Pacific
  • Fig. 103 Asia Pacific market estimates and forecast, 2018 - 2030 (USD Billion, volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Fig. 104 Japan key country dynamics
  • Fig. 105 Japan market estimates and forecast, 2018 - 2030 (USD Billion, volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Fig. 106 China key country dynamics
  • Fig. 107 China. market estimates and forecast, 2018 - 2030 (USD Billion, volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Fig. 108 India key country dynamics
  • Fig. 109 India. market estimates and forecast, 2018 - 2030 (USD Billion, volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Fig. 110 South Korea key country dynamics
  • Fig. 111 South Korea market estimates and forecast, 2018 - 2030 (USD Billion, volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Fig. 112 Thailand key country dynamics
  • Fig. 113 Thailand market estimates and forecast, 2018 - 2030 (USD Billion, volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Fig. 114 Australia key country dynamics
  • Fig. 115 Australia market estimates and forecast, 2018 - 2030 (USD Billion, volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Fig. 116 Latin America
  • Fig. 117 Latin America market estimates and forecast, 2018 - 2030 (USD Billion, volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Fig. 118 Brazil key country dynamics
  • Fig. 119 Brazil market estimates and forecast, 2018 - 2030 (USD Billion, volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Fig. 120 Argentina key country dynamics
  • Fig. 121 Argentina market estimates and forecast, 2018 - 2030 (USD Billion, volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Fig. 122 MEA
  • Fig. 123 MEA market estimates and forecast, 2018 - 2030 (USD Billion, volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Fig. 124 South Africa key country dynamics
  • Fig. 125 South Africa market estimates and forecast, 2018 - 2030 (USD Billion, volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Fig. 126 UAE key country dynamics
  • Fig. 127 UAE market estimates and forecast, 2018 - 2030 (USD Billion, volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Fig. 128 Saudi Arabia key country dynamics
  • Fig. 129 Saudi Arabia market estimates and forecast, 2018 - 2030 (USD Billion, volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Fig. 130 Ansoff matrix
  • Fig. 131 Competition categorization
  • Fig. 132 Company market share analysis, 2024
  • Fig. 133 Global mass spectrometry company market share analysis, 2024
  • Fig. 134 North America mass spectrometry company market share analysis, 2024
  • Fig. 135 Europe mass spectrometry company market share analysis, 2024
  • Fig. 136 Asia Pacific mass spectrometry company market share analysis, 2024
  • Fig. 137 Global immunoassay company market share analysis, 2024
  • Fig. 138 North America immunoassay company market share analysis, 2024
  • Fig. 139 Europe immunoassay company market share analysis, 2024
  • Fig. 140 Asia Pacific immunoassay company market share analysis, 2024
  • Fig. 141 Global PCR company market share analysis, 2024
  • Fig. 142 North America PCR company market share analysis, 2024
  • Fig. 143 Europe PCR company market share analysis, 2024
  • Fig. 144 Asia Pacific PCR company market share analysis, 2024
  • Fig. 145 Company market position analysis
  • Fig. 146 Company market position analysis
  • Fig. 147 Company market position analysis
  • Fig. 148 Company profiles
  • Fig. 149 Regional network map